Table 2 Open in new tab Zero-Order...

Pain Self-Efficacy

Pain Catastrophizing

Pain Intensity—Baseline

Pain Intensity—12 Weeks

Pain self-efficacy

All participants

- - - - - - -

−0.60^a (−0.51 to −0.67) (n = 259)

−0.39^a (−0.28 to −0.49) (n = 260)

−0.32^a (−0.19 to −0.44) (n = 212)

Black

- - - - - - -

−0.64^a (−0.44 to −0.78) (n = 49)

−0.42^a (−0.16 to −0.62) (n = 50)

−0.29 (0.03 to −0.56) (n = 38)

Non-Hispanic White

- - - - - - -

−0.57^a (−0.47 to −0.66) (n = 210)

−0.37^a (−0.25 to −0.48) (n = 210)

−0.32^a (−0.18 to −0.45) (n = 174)

Pain catastrophizing

All participants

- - - - - - -

0.39^a (0.28 to 0.49) (n = 260)

0.34^a (0.21 to 0.46) (n = 212)

Black

- - - - - - -

0.47^a (0.22 to 0.66) (n = 50)

0.44^b (0.14 to 0.67) (n = 38)

Non-Hispanic White

- - - - - - -

0.35^a (0.22 to 0.46) (n = 210)

0.30^a (0.15 to 0.43) (n = 174)

Pain intensity—baseline

All participants

- - - - - - -

0.41^a (0.30 to 0.52) (n = 220)

Black

- - - - - - -

0.59^a (0.34 to 0.77) (n = 39)

Non-Hispanic White

- - - - - - -

0.38^a (0.25 to 0.50) (n = 181)

Table 2

Open in new tab

Zero-Order Correlations With 95% CI Among Mediators and Pain Intensity Scores at Baseline and After 12-Weeks

		Pain Self-Efficacy	Pain Catastrophizing	Pain Intensity—Baseline	Pain Intensity—12 Weeks
Pain self-efficacy	All participants	- - - - - - -	−0.60^a (−0.51 to −0.67) (n = 259)	−0.39^a (−0.28 to −0.49) (n = 260)	−0.32^a (−0.19 to −0.44) (n = 212)
	Black	- - - - - - -	−0.64^a (−0.44 to −0.78) (n = 49)	−0.42^a (−0.16 to −0.62) (n = 50)	−0.29 (0.03 to −0.56) (n = 38)
	Non-Hispanic White	- - - - - - -	−0.57^a (−0.47 to −0.66) (n = 210)	−0.37^a (−0.25 to −0.48) (n = 210)	−0.32^a (−0.18 to −0.45) (n = 174)
Pain catastrophizing	All participants	- - - - - - -	- - - - - - -	0.39^a (0.28 to 0.49) (n = 260)	0.34^a (0.21 to 0.46) (n = 212)
	Black	- - - - - - -	- - - - - - -	0.47^a (0.22 to 0.66) (n = 50)	0.44^b (0.14 to 0.67) (n = 38)
	Non-Hispanic White	- - - - - - -	- - - - - - -	0.35^a (0.22 to 0.46) (n = 210)	0.30^a (0.15 to 0.43) (n = 174)
Pain intensity—baseline	All participants	- - - - - - -	- - - - - - -	- - - - - - -	0.41^a (0.30 to 0.52) (n = 220)
	Black	- - - - - - -	- - - - - - -	- - - - - - -	0.59^a (0.34 to 0.77) (n = 39)
	Non-Hispanic White	- - - - - - -	- - - - - - -	- - - - - - -	0.38^a (0.25 to 0.50) (n = 181)

		Pain Self-Efficacy	Pain Catastrophizing	Pain Intensity—Baseline	Pain Intensity—12 Weeks
Pain self-efficacy	All participants	- - - - - - -	−0.60^a (−0.51 to −0.67) (n = 259)	−0.39^a (−0.28 to −0.49) (n = 260)	−0.32^a (−0.19 to −0.44) (n = 212)
	Black	- - - - - - -	−0.64^a (−0.44 to −0.78) (n = 49)	−0.42^a (−0.16 to −0.62) (n = 50)	−0.29 (0.03 to −0.56) (n = 38)
	Non-Hispanic White	- - - - - - -	−0.57^a (−0.47 to −0.66) (n = 210)	−0.37^a (−0.25 to −0.48) (n = 210)	−0.32^a (−0.18 to −0.45) (n = 174)
Pain catastrophizing	All participants	- - - - - - -	- - - - - - -	0.39^a (0.28 to 0.49) (n = 260)	0.34^a (0.21 to 0.46) (n = 212)
	Black	- - - - - - -	- - - - - - -	0.47^a (0.22 to 0.66) (n = 50)	0.44^b (0.14 to 0.67) (n = 38)
	Non-Hispanic White	- - - - - - -	- - - - - - -	0.35^a (0.22 to 0.46) (n = 210)	0.30^a (0.15 to 0.43) (n = 174)
Pain intensity—baseline	All participants	- - - - - - -	- - - - - - -	- - - - - - -	0.41^a (0.30 to 0.52) (n = 220)
	Black	- - - - - - -	- - - - - - -	- - - - - - -	0.59^a (0.34 to 0.77) (n = 39)
	Non-Hispanic White	- - - - - - -	- - - - - - -	- - - - - - -	0.38^a (0.25 to 0.50) (n = 181)

P < .01.

P < .05.

This Feature Is Available To Subscribers Only